The most common adverse effects recorded with 9vHPV are injection-site events, systemic events, and syncope.

A 2016 study concluded that incidences of adverse effects were comparable throughout all the age groups.

Postmarketing surveillance of the human papillomavirus vaccine has identified multiple AEFI (adverse events following immunization) such as abdominal pain, syncope, dizziness, loss of consciousness, alopecia, amenorrhea, anemia, dyskinesia, migraine, pallor, and seizures.